Immunocore Holdings plc
IMCR
$33.30
$1.434.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 97.96M | 93.88M | 84.05M | 80.25M | 75.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 97.96M | 93.88M | 84.05M | 80.25M | 75.40M |
| Cost of Revenue | 70.05M | 831.00K | -147.23M | 51.40M | 52.78M |
| Gross Profit | 27.92M | 93.05M | 231.28M | 28.85M | 22.62M |
| SG&A Expenses | 42.79M | 40.20M | 42.32M | 35.53M | 38.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -18.05M | -- | -- |
| Total Operating Expenses | 112.84M | 97.50M | 85.45M | 88.75M | 91.42M |
| Operating Income | -14.88M | -3.62M | -1.40M | -8.50M | -16.02M |
| Income Before Tax | -9.69M | 6.08M | -24.82M | 6.09M | -10.13M |
| Income Tax Expenses | 606.00K | 1.06M | -1.05M | -2.64M | 1.49M |
| Earnings from Continuing Operations | -10.30M | 5.02M | -23.77M | 8.74M | -11.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.30M | 5.02M | -23.77M | 8.74M | -11.62M |
| EBIT | -14.88M | -3.62M | -1.40M | -8.50M | -16.02M |
| EBITDA | -14.10M | -2.76M | -235.00K | -7.47M | -15.03M |
| EPS Basic | -0.20 | 0.10 | -0.48 | 0.17 | -0.23 |
| Normalized Basic EPS | -0.12 | 0.01 | -0.26 | 0.08 | -0.13 |
| EPS Diluted | -0.20 | 0.10 | -0.48 | 0.17 | -0.23 |
| Normalized Diluted EPS | -0.12 | 0.01 | -0.26 | 0.07 | -0.13 |
| Average Basic Shares Outstanding | 50.29M | 50.09M | 50.05M | 50.02M | 50.01M |
| Average Diluted Shares Outstanding | 50.29M | 51.95M | 50.05M | 52.81M | 50.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |